Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at ...

Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...

Factors linked to heart problems, such as high blood pressure, diabetes and bad cholesterol levels, can start years, ...

Despite advancements in treatment and prevention, patients with established atherosclerotic cardiovascular disease (ASCVD) still have particularly high risk of having another heart attack, stroke, or ...

Cardiovascular diseases (CVDs) are the leading cause of non-communicable disease (NCD) deaths in India, accounting for nearly ...

Once-weekly semaglutide 2.4 mg reduced the risk for major adverse cardiovascular events among adults with overweight or obesity who were at risk for atherosclerotic cardiovascular disease, according ...

The Family Heart Foundation, a non-profit research and advocacy organization to lead research and education, focusing on genetic dyslipidemias, has launched the Lp(a) AW(a)RE initiative to engage key ...

Adding the PCSK9 inhibitor evolocumab to a high-intensity, cholesterol-lowering regimen reduced the risk of a first major ...

Discover Enlicitide, a new daily pill for genetic high cholesterol (HeFH). A recent trial shows it lowers bad LDL cholesterol ...